Deficits, Adaptation and Cerebral Functional Reorganization of Visual Retinotopic Treatments During Normal and Pathological Aging (Age-related Macular Degeneration and Glaucoma) (VISIOPERICENT)
Sponsor: Laboratoire de Psychologie et NeuroCognition
Terminated
not enough patients
Other terminated trials from Laboratoire de Psychologie et NeuroCognition
See all terminations from Laboratoire de Psychologie et NeuroCognition
A NA clinical study on Glaucoma and Macular Degeneration, this trial is terminated or withdrawn. The trial is conducted by Laboratoire de Psychologie et NeuroCognition and has accumulated 8 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Sep 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jan 2020 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 3 earlier versions
-
Nov 2018 — Jan 2020 [monthly]
Recruiting NA
-
Jun 2018 — Nov 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Feb 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Laboratoire de Psychologie et NeuroCognition
- University Hospital, Grenoble
For direct contact, visit the study record on ClinicalTrials.gov .